Work

Population pharmacokinetic (PPK) analysis for 5-FU, tegafur (FT), gimeracil (CDHP), and oteracil potassium (Oxo) in the eight clinical studies of S-1 in Western patients with advanced solid tumors.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.4_suppl.53

Authors: K. Yoshida, K. Ikeda, K. Yoshisue, W. Rodriguez, G. Bodoky, V. Moiseyenko, M. Lichinitser, K. Saito, F. M. Benedetti, J. A. Ajani, The FLAGS Trial Investigators Group

Institutions: Russian Cancer Research Center NN Blokhin, Institute of Oncology NN Petrov, Taiho Pharmaceutical (Japan), Taiho Oncology (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2460291089

Cites:

Cited by: 4

Related to: 10